The annual Controlling Cancer Summit in an international academic event with plenty of opportunity for networking and debate. In an informal setting, this meeting will bring you up to date with current research and thinking regarding screening, prevention and treatment in this ever-growing field. Presenting at this event, we will have a variety of clinicians, academics and members of the pharmaceutical industry; we encourage presentations from the wide spectrum of cancer research, development and healthcare professionals.
A late registration fee applies after March 20th 2016
This innovative and stimulating event will is aimed at those working in research and development of drugs, industry partners, academia, biotechnology, diagnostics, clinicians and postgraduate students.
Hashtag: #cancer2016
This event has an open abstract session.
Abstracts can be submitted on any subject related to cancer.
The Deadline for abstract submissions for oral presentation is February 10th 2016.
Abstracts for poster presentation only can be submitted up to two weeks before the event.
You can download the instructions for authors at: www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf
This event has CPD accreditation
A late registration fee applies after March 20th 2016
This innovative and stimulating event will is aimed at those working in research and development of drugs, industry partners, academia, biotechnology, diagnostics, clinicians and postgraduate students.
Hashtag: #cancer2016
This event has an open abstract session.
Abstracts can be submitted on any subject related to cancer.
The Deadline for abstract submissions for oral presentation is February 10th 2016.
Abstracts for poster presentation only can be submitted up to two weeks before the event.
You can download the instructions for authors at: www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf
This event has CPD accreditation
